Honorary Editor-in-Chief: Haibo Song; Editors-in-Chief: Hualiang Wang & Hengjun Gao
VIEW is an open access journal for interdisciplinary research focused on “biodiagnostics” in the field of biomaterials. Coverage spans from in vitro to in vivo, and from fundamentals to application, with an emphasis on the biomaterials used particularly in biotechnology and medicine.
VIEW aims to turn research into innovation, publishing full-length research articles, communications, reviews and mini-reviews, as well as perspectives, case reports, analysis, and other editorial content of general interest to the field of biomaterials.
Journal Metrics
- 14.5CiteScore
- 8.5Journal Impact Factor
- 34%Acceptance rate
- 30 days Submission to first decision
Why publish in VIEW?
- Open access means your research is available to read, download, and share.
- An opportunity for transforming research excellence to innovation with an aspiring premier journal.
- Dedicated special issues make your work easily discoverable to like-minded scientists.
- Published in partnership with the Professional Community of Experimental Medicine. By partnering directly with the community, we've built up the trust to help drive change faster, together.
VIEW embraces all significant advances in research fields including drug delivery, lab-on-a-chip, microfluidics, bioimaging, biomarkers, omics, biosensors and bioelectronics, computational diagnostics, bioinformatics, and novel diagnostic devices, and more.
Submit your paper here.
Announcement
Hear from our Associate Editor, Prof. Dr. Kun Qian!
On the Cover
VIEW embraces all significant advances in the research of: Drug delivery, Lab-on-a-chip, Microfluidics, Bioimaging, Bio-markers, Omics, Biosensors and bio-electronics, Computational diagnostics, Bioinformatics, and Novel diagnostic devices, etc.
VIEW publishes full-length research articles, communications, reviews, mini-reviews, perspectives, case reports, analysis and other editorial content of general interest to the field of biomaterials. VIEW aims to be a premier journal for researchers in both academia and industry, providing a platform for transforming research excellence to innovation.
VIEW cordially invites you to submit original research and review articles. All papers will be published online as soon as they are accepted and will be fully citable. In addition, there are no article publication charges for the first three publication years of VIEW.
In article number 20, Ying‐Wei Yang and co‐workers describe metal‐organic framework (MOF)‐based theranostic nanoplatforms that integrate various imaging technologies and treatment strategies have been extensively investigated to improve the diagnosis and treatment of cancer. In this cover, a MOF‐loaded carriage dragged by two horses (one horse represents imaging technologies and the other means treatment strategies) is transported to the castle, symbolizing that MOFs as multifunctional theranostic tools could deliver cargos to the tumor sites for precise cancer therapy guided by various imaging technologies.
In article number 20200034, Pietro Ferraro and co‐workers emphasize that early detection in cancer diseases is a key issue. The current state of the art of technology could allow a great opportunity for this purpose, to develop systems for detecting circulating cancer cells (CTC) in the blood. The challenge is to recognize and classify cancer cells and detect them non‐invasively through a lab‐on‐chip device as they flow. Single‐cell holographic phase contrast tomography offers the possibility in the real world to detect CTC in a label‐free mode by means of morphological analyzes when combined with artificial intelligence (AI). The cover summarizes and depicts the main concepts and the technological ingredients necessary to achieve such an ambitious goal, namely the recognition and sorting of cells, 3D‐imaging by microscope and complete morphological analysis of 3D‐phase‐contrast tomograms by AI tools.
In article number 20200006, Yi‐Tao Long, Yi‐Lun Ying and co‐workers display that aerolysin single‐biomolecule interface is developed to achieve single molecule sensing in a label free manner. To further enhance the sensing performance, sensing regions of Aerolysin nanopore are first determined by the combination of nanopore experiments and molecular dynamics simulation. Aerolysin sensing interface is subsequently designed and tailored at the precision of chemical group via site‐directed mutagenesis. After the well‐designed mutagenesis, electrochemically confined mutant Aerolysin nanopore shows the extremely high selectivity and sensitivity toward target single biomolecules, being further expecting to be widely applied in fast disease diagnosis and protein sequencing.
Your work will be discoverable and widely distributed!
VIEW is now indexed by Emerging Sources Citation Index (Clarivate Analytics), Web of Science (Clarivate Analytics), CAS: Chemical Abstracts Service (ACS), Scopus (Elsevier), Ei COMPENDEX (Elsevier), INSPEC (IET) and the Directory of Open Access Journals, which will help increase the discoverability of your work.
Articles
Targeting the SOD1‒MMP‐2‒COLXVII axis: A therapeutic strategy for age‐related tissue degeneration
- 17 July 2025
Graphical Abstract
Our work identifies a novel role for MMP-2 in driving senescence-associated skin and muscle degeneration through ECM degradation. We demonstrate that inhibiting MMP-2 activity restores tissue integrity by preserving COLXVII, revealing a new therapeutic pathway for combating oxidative stress-induced tissue aging. Using both mammalian and nematode models, we provide robust evidence that targeting the SOD1‒MMP-2‒COLXVII axis can reverse aging-related structural and functional declines, offering translational potential for clinical intervention in age-related disorders.
Brain metastasis in non‐small cell lung cancer: High‐risk factors and predictive models
- 8 July 2025
Graphical Abstract
Artificial intelligence (AI) can integrate of data to predict brain metastases (BM) in non-small cell lung cancer (NSCLC). AI algorithms are employed to analyze these multifaceted datasets, enabling the identification of complex patterns and correlations that may not be apparent through traditional analytical methods. The data integration process encompasses a wide range of factors, including clinical and pathological characteristics, biological markers, genomic information, radiomic features, microbiome elements, tumor microenvironment dynamics, and historical treatment records.
Photoacoustic integrated multimodal imaging for breast cancer diagnosis: A review
- 8 July 2025
Graphical Abstract
Breast cancer is a complex and challenging to diagnose. This study highlights how combining photoacoustic imaging with traditional techniques like mammography, histopathology, ultrasound, MRI, CT, and artificial intelligence can improve diagnosis, tumor classification, and managing. The integration promises more precise, and noninvasive diagnosis with better disease management and patient outcomes.
A paper‐based bi‐enzymatic sensor for chemiresistive glucose detection
- 3 July 2025
Graphical Abstract
This paper presents the development of a paper-based glucose sensor utilizing poly(3,4-ethylene-dioxythiophene) polystyrene sulfonate (PEDOT:PSS) and a bi-enzymatic system with Horseradish Peroxidase (HRP) and Glucose Oxidase (GOx). The chemiresistive sensor is optimized for detecting glucose in biofluids such as saliva, requiring only 40 µL of sample volume and exhibiting a detection limit of 1.1 µM with a linear range of 102–104 µM.
Extracellular vesicles derived from silicate‐stimulated antler reserve mesenchymal cells alleviate kidney damage in diabetic nephropathy through inhibiting abnormal angiogenesis and apoptosis
- 2 July 2025
Graphical Abstract
A novel bioengineering platform was invented to harness simple silicate ions to command highly regenerative deer antler cells, transforming them into super-factories that massively produce customized extracellular vesicles (Si-RM-EVs) rich in therapeutic miR-148a-3p, dwarfing natural EV output and payload. These precisionally engineered Si-RM-EVs achieved striking reversal of diabetic kidney damage in mice via simultaneously inhibiting abnormal angiogenesis and apoptosis, proving a promising cell-free therapeutic strategy with vast potential to regenerate damaged organs beside kidney.
The following is a list of the most cited articles based on citations published in the last three years, according to CrossRef.
Biosensors and sensors for dopamine detection
- 13 September 2020
Graphical Abstract
Enzymes, aptamers, antibodies, and molecularly imprinted polymers have been developed to detect dopamine using electrochemical and optical signaling methods to address the analytical needs of fast, selective, sensitive, and in situ analysis of dopamine. On this topic, potential artifacts for sensor design are also critically evaluated.
Recent development of nanomedicine for the treatment of bacterial biofilm infections
- 14 October 2020
Graphical Abstract
Bacterial biofilm related infections are ever growing threats for global medical community. However, traditional antibiotic therapy is usually ineffective for eradicating bacterial biofilms. In this review, recent development of nanomedicine to treat bacterial biofilm infections is introduced, and typical therapeutic strategies based on nanotechnology are summarized and discussed herein.
Stimuli‐responsive hydrogels: Fabrication and biomedical applications
- 27 August 2021
Graphical Abstract
In this review, the authors aim to provide guidelines for researchers to design stimuli-responsive hydrogels of their own interest. Different kinds of construction mode including supramolecular assembly, radical polymerization, chemical reaction and so on are introduced. Different hydrogels response to contact and non-contact, synthetic and natural, and endogenous and exogenous signal are discussed. Various applications developed and will be developed in the future are evaluated, especially in the field of tissue engineering and regeneration medicine, which are still at its primary stage and in an urgent need of development. The growing of stimuli-responsive hydrogels is expected to contribute to this field and provide promising perspectives.
Type I AIE photosensitizers: Mechanism and application
- 13 July 2021
Graphical Abstract
Photodynamic therapy (PDT) is emerging as a promising cancer therapeutic treatment and receiving increasing interests. Focusing on this specific theme, this review presents a detailed introduction on the PDT mechanism, summarizes the detection methods for the nature of reactive oxygen species, and discusses the superiority of Type I photosensitizers with aggregation-induced emission (AIE) property. At last, the latest advances on Type I AIE photosensitizers are reviewed.
Bionanoparticles in cancer imaging, diagnosis, and treatment
- 15 March 2022
Graphical Abstract
The natural and artificial biological molecules, such as the DNA, proteins, and lipids, could be assembled into bionanoparticles such as bacterial viruses (i.e., bacteriophages or phages), plant viruses, DNA origami, protein nanoparticles, and exosomes. Here, we review their applications in cancer imaging, diagnosis, and treatment and highlight their distinct properties.
Recent issues
Volume 6, Issue 3June 2025
Volume 6, Issue 2April 2025
Volume 6, Issue 1February 2025
Volume 5, Issue 6December 2024
Latest news
Sign up for email alerts
Tools
VIEW is a high-quality, interdisciplinary and rapid-publication journal focused on “Biodiagnostics” in the field of biomaterials, from in vitro to in vivo, small to mega, fundamentals to application with the emphasis on the biomaterials used particularly in biotechnology and medicine.
Related Materials Open-access journals
Carbon Energy (2019-Present)
EcoMat (2019-Present)
SmartMat (2020-Present)
SusMat (2021-Present)
InfoMat (2019-Present)